Plaquenil (International)

In the US, Plaquenil (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lupus, Lyme Disease - Arthritis, Malaria, Malaria Prevention and Rheumatoid Arthritis.

US matches:

• Plaquenil

Ingredient matches for Plaquenil

Hydroxychloroquine

Hydroxychloroquine is reported as an ingredient of Plaquenil in the following countries:

• Tunisia
• United States

Hydroxychloroquine sulfate (a derivative of Hydroxychloroquine) is reported as an ingredient of Plaquenil in the following countries:

• Argentina
• Australia
• Belgium
• Canada
• China
• Cyprus
• Czech Republic
• Denmark
• Egypt
• Estonia
• France
• Georgia
• Greece
• Hong Kong
• Iceland
• Ireland
• Israel
• Italy
• Japan
• Kuwait
• Latvia
• Lithuania
• Malaysia
• Malta
• Mexico
• Netherlands
• New Zealand
• Norway
• Philippines
• Romania
• Slovakia
• Sweden
• Taiwan
• Thailand
• Turkey

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer